Page last updated: 2024-08-17

bromodeoxyuridine and Astrocytoma, Grade IV

bromodeoxyuridine has been researched along with Astrocytoma, Grade IV in 64 studies

Research

Studies (64)

Timeframe	Studies, this research(%)	All Research%
pre-1990	23 (35.94)	18.7374
1990's	20 (31.25)	18.2507
2000's	9 (14.06)	29.6817
2010's	10 (15.63)	24.3611
2020's	2 (3.13)	2.80

Authors

Authors	Studies
Hacioglu, C; Kar, F	1
Cai, HR; Cui, HJ; Sun, W; Tang, WH; Yang, H; Zhang, ZN; Zhao, EH	1
Biltekin, B; Çetin, A; Degirmencioglu, S	1
Cao, L; Chen, J; Hu, J; Lin, J; Lin, S; Mao, L; Ouyang, Y; Yan, G; Yang, X; Zhang, H; Zhou, Y; Zhu, W	1
Csaba, N; de la Fuente, M; Garcia-Fuentes, M; Hardy, E; Reguera-Nuñez, E; Roca, C	1
Chung, G; Coxon, A; Jun, T; Kaplan-Lefko, P; Kendall, R; Manoukian, R; Oliner, J; Payton, M; Radinsky, R; Scully, S; Sun, JR; Van, G; Wayne, W; Yu, D; Zhang, N	1
Barrecheguren, PJ; Cotrufo, T; Gonzàlez-Juncà, A; Martínez-Mármol, R; Meffre, D; Olivé, N; Pazos, I; Seoane, J; Soriano, E; Ulloa, F	1
Hamaoka, Y; Katoh, H; Negishi, M	1
Bezerra, DP; Câmara, CA; Cavalcanti, BC; Costa-Lotufo, LV; Lima, MA; Magalhães, HI; Moraes, MO; Pessoa, C; Rao, VS; Silveira, ER	1
Chen, YY; Li, BA; Liu, XY; Shen, SH; Tan, GW; Wang, HD; Wang, ZX; Zhu, HW	1
Bieńkowski, M; Grešner, SM; Hułas-Bigoszewska, K; Ironside, JW; Jaskólski, DJ; Kolasa, M; Kulczycka-Wojdala, D; Liberski, PP; Papierz, W; Piaskowski, S; Rieske, P; Stawski, R; Stoczyńska-Fidelus, E; Witusik-Perkowska, M; Zakrzewska, M; Zakrzewski, K	1
Kogure, S; Murayama, H; Sadakane, K; Yamanoha, B	1
Cordes, N; Eke, I; Faethe, C; Kästner, I; Mueller-Klieser, W; Schackert, G; Storch, K; Taucher-Scholz, G; Temme, A; Vehlow, A	1
Bartkowiak, D; Nusser, NN; Röttinger, EM	1
Hashimoto, I; Ide, W; Kamada, H; Kumagai, M; Matsuyama, N; Murakami, H; Nakasato, M; Satone, A; Sawa, H; Tamura, Y; Yamauchi, S	1
Archer, DR; Ciliax, B; Davis, T; Glass, JD; Hau, V; Joshi, HC; Landen, JW; Van Meir, EG; Wainer, BH; Wang, M	1
Balázs, M; Feuerstein, BG; Fulwyler, MJ; Hyun, WC; Szöllosi, J; Vereb, G	1
Alam, G; Cui, H; Ding, HF; Ding, J; Li, T; Ma, J	1
Hagemeier, C; Henze, G; Holtkamp, N; Krabbe, S; Kunitz, F; Lass, U; Riabowol, KT; Sinn, B; Tallen, UG; Truss, M; Unryn, B; von Deimling, A; Wellmann, S; Wurm, R	1
Barone, TA; DeChant, A; Hoffer, A; Lock, J; Mangla, S; Miller, RH; Morrow, J; Plunkett, RJ; Selkirk, SM	1
Aiken, M; Glatstein, E; Hsu, SM; Kinsella, TJ; Mitchell, JB; Morstyn, G; Rowland, J; Russo, A	1
Glatstein, E; Kinsella, TJ; Kornblith, PL; McPherson, S; Mitchell, JB; Rowland, J; Russo, A; Smith, BH	1
Kohno, T; Shitara, N; Takakura, K	1
Th'ng, JP; Walker, IG	1
Collins, JM; Jenkins, J; Kinsella, TJ; Kornblith, P; Mitchell, JB; Myers, CE; Rowland, J; Russo, A; Schwade, J; Speyer, J	1
Davis, RL; Hoshino, T; Onda, K; Shibuya, M; Wilson, CB	1
Davis, RL; Gutin, PH; Lamborn, K; Levin, VA; Phillips, TL; Prados, MR; Wara, WM; Wilson, CB	1
Bruner, JM; Hess, KR; Levin, VA; Ritter, AM; Sawaya, R	1
Davis, RL; Hoshino, T; Onda, K; Wilson, CB	1
Ahn, D; Hoshino, T; Lamborn, K; Prados, MD; Wilson, CB	1
Davis, RL; Hoshino, T; Ito, S; Shibuya, M	1
Dinda, AK; Karak, AK; Kharbanda, K; Mathur, M; Roy, S; Sarkar, C	1
Barker, FG; Chang, SM; Davis, RL; Gutin, PH; Lamborn, KR; Larson, DA; McDermott, MW; Prados, MD; Sneed, PK; Wilson, CB	1
Bailey, SF; Fuhr, JE; Kabalka, GW	1
Bussink, J; Kaanders, JH; Martindale, CA; Rijken, PF; van der Kogel, AJ	1
Asbell, S; Comis, R; Curran, W; Davis, RL; Lamborn, K; Levin, VA; Murray, K; Nelson, J; Phillips, TL; Prados, MD; Rotman, M; Rubin, P; Sause, W; Scott, CB	1
Begemann, M; Bruce, JN; Choi, YA; Christiansen, KM; Duigou, G; Fabbro, D; Ghosh, S; Heitjan, DF; Kashimawo, SA; Kim, S; Lampen, NM; Mueller, M; Schieren, I; Schiff, PB; Weinstein, IB	1
Bruner, JM; Groves, MD; Hess, K; Jaeckle, KA; Kyritsis, AP; Levin, VA; Maor, MH; Meyers, C; Peterson, P; Sawaya, RE; Yung, WK	1
Ostruszka, LJ; Shewach, DS	1
Mundinger, F; Ostertag, C	1
Bokhari, SA; Miller, MA; Qadir, K; Raza, A	1
Cogen, PH; Davis, RL; Edwards, MS; Hoshino, T; Krouwer, HG; Prados, MD	1
Isoe, S; Kawaoi, A; Kimura, R; Naganuma, H; Nakano, S; Nukui, H; Sasaki, A; Suzuki, K	1
Batorski, L; Daumas-Duport, C; Hoshino, T; Labrousse, F	1
Ahn, DK; Davis, RL; Flam, MS; Gutin, PH; Levin, VA; Phillips, TL; Prados, MD; Wara, WM; Wilson, CB	1
Kinsella, TJ; Rodriguez, R	1
Chandler, WF; Diaz, RF; Ensminger, WD; Gebarski, SS; Hegarty, TJ; Hood, TW; Junck, L; Page, MA; Stetson, PL; Thornton, AF	1
Hirakawa, K; Houri, T; Ibayashi, N; Nakamura, K; Suzuki, K	1
Aoki, H; Furutani, Y; Ikeyama, Y; Nishizaki, T; Orita, T; Sasaki, K	1
Cho, KG; Davis, RL; Hoshino, T; Lee, KS; Prados, M; Wilson, CB	1
Cho, KG; Davis, RL; Donegan, J; Hoshino, T; Nagashima, T; Slusarz, M; Wilson, CB	1
Collins, J; Glatstein, E; Jackson, D; Katz, D; Kinsella, T; Kornblith, P; Main, D; Rowland, J; Wright, D	1
Hayakawa, T; Mogami, H; Yoshimine, T	1
DeArmond, SJ; Hoshino, T; Murovic, J; Nagashima, T	1
Hoshino, T; Levin, EM; Levin, VA; Murovic, J; Nagashima, T; Rupp, SM	1
Breathnach, SM; Fine, JD	1
Davis, RL; Edwards, MS; Hoshino, T; Murovic, JA; Nagashima, T	1
Cho, KG; Hoshino, T; Nagashima, T	1
Hoshino, T	2
Hoshino, T; Wilson, CB	1
Landolt, AM	1
Koyama, Y; Matsutani, M; Sing, OK; Takakura, K	1
Mundinger, F	1

Reviews

1 review(s) available for bromodeoxyuridine and Astrocytoma, Grade IV

Article	Year
[Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma]. Rinsho hoshasen. Clinical radiography, 1968, Volume: 13, Issue:11 Topics: Brain Neoplasms; Bromodeoxyuridine; Glioblastoma; Humans; Radiation-Sensitizing Agents	1968

Trials

6 trial(s) available for bromodeoxyuridine and Astrocytoma, Grade IV

Article	Year
Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. International journal of radiation oncology, biology, physics, 1995, Apr-30, Volume: 32, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Disease-Free Survival; Glioblastoma; Humans; Lomustine; Middle Aged; Procarbazine; Vincristine	1995
Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival. International journal of radiation oncology, biology, physics, 1996, Mar-01, Volume: 34, Issue:4 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Female; Glioblastoma; Humans; Male; Middle Aged; Sex Factors; Survival Analysis	1996
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme. International journal of radiation oncology, biology, physics, 1999, Aug-01, Volume: 45, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bromodeoxyuridine; Cognition; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Reoperation; Vincristine	1999
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. International journal of radiation oncology, biology, physics, 1991, Volume: 21, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Drug Evaluation; Female; Glioblastoma; Humans; Infusions, Intravenous; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Survival Analysis; Vincristine	1991
Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas. International journal of radiation oncology, biology, physics, 1990, Volume: 19, Issue:2 Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Clinical Trials as Topic; Combined Modality Therapy; Female; Glioblastoma; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Middle Aged; Radiation-Sensitizing Agents; Survival Analysis; United States	1990
Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme. American journal of clinical oncology, 1987, Volume: 10, Issue:5 Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Drug Evaluation; Female; Glioblastoma; Humans; Idoxuridine; Infusions, Intravenous; Male; Middle Aged; Prognosis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Subclavian Vein; Time Factors	1987

Other Studies

57 other study(ies) available for bromodeoxyuridine and Astrocytoma, Grade IV

Article	Year
Capsaicin induces redox imbalance and ferroptosis through ACSL4/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells. Metabolic brain disease, 2023, Volume: 38, Issue:2 Topics: Bromodeoxyuridine; Capsaicin; Cell Line, Tumor; Ferroptosis; Glioblastoma; Humans; Oxidation-Reduction; RNA, Messenger; Signal Transduction	2023
[Effect of Morus alba extract sanggenon C on growth and proliferation of glioblastoma cells]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2023, Volume: 48, Issue:1 Topics: Agar; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Jumonji Domain-Containing Histone Demethylases; Proto-Oncogene Proteins c-myc; Signal Transduction	2023
Ellagic Acid Enhances the Antitumor Efficacy of Bevacizumab in an In Vitro Glioblastoma Model. World neurosurgery, 2019, Volume: 132 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Apoptosis; Bevacizumab; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; DNA Repair; Drug Resistance, Neoplasm; Drug Synergism; Ellagic Acid; Gene Expression Regulation, Neoplastic; Glioblastoma; Rats	2019
Diazepam inhibits proliferation of human glioblastoma cells through triggering a G0/G1 cell cycle arrest. Journal of neurosurgical anesthesiology, 2013, Volume: 25, Issue:3 Topics: Antimetabolites; Benzimidazoles; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Diazepam; Fluorescent Dyes; G1 Phase; G1 Phase Cell Cycle Checkpoints; GABA Modulators; Glioblastoma; Humans; L-Lactate Dehydrogenase; Resting Phase, Cell Cycle; S Phase; Tetrazolium Salts; Thiazoles	2013
Implantable controlled release devices for BMP-7 delivery and suppression of glioblastoma initiating cells. Biomaterials, 2014, Volume: 35, Issue:9 Topics: Antineoplastic Agents; Bone Morphogenetic Protein 7; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Delayed-Action Preparations; Glioblastoma; Humans; Microspheres; Nanoparticles; Neoplastic Stem Cells; Polymers; Prostheses and Implants; Spheroids, Cellular	2014
Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method. Laboratory investigation; a journal of technical methods and pathology, 2014, Volume: 94, Issue:11 Topics: Animals; Antibodies, Neutralizing; Bromodeoxyuridine; Cell Proliferation; Colorectal Neoplasms; Endothelial Cells; Female; Flow Cytometry; Glioblastoma; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice, Nude; Neoplasms, Experimental; Receptor, TIE-2; Recombinant Fusion Proteins; Xenograft Model Antitumor Assays	2014
Blockade of the SNARE protein syntaxin 1 inhibits glioblastoma tumor growth. PloS one, 2015, Volume: 10, Issue:3 Topics: Animals; Blotting, Western; Botulinum Toxins; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Glioblastoma; Humans; Lentivirus; Mice; Neoplasm Invasiveness; RNA, Small Interfering; Statistics, Nonparametric; Syntaxin 1; Transduction, Genetic	2015
EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation. Cellular signalling, 2016, Volume: 28, Issue:8 Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; Glioblastoma; Humans; MAP Kinase Signaling System; Phosphorylation; Phosphoserine; Receptor, EphA2; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction	2016
Kauren-19-oic acid induces DNA damage followed by apoptosis in human leukemia cells. Journal of applied toxicology : JAT, 2009, Volume: 29, Issue:7 Topics: Acridine Orange; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Comet Assay; Diterpenes; DNA Damage; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ethidium; Fluorescent Dyes; Glioblastoma; HL-60 Cells; Humans; Inhibitory Concentration 50; Intercalating Agents; K562 Cells; Leukemia; Melanoma; Molecular Structure; Necrosis	2009
Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth. Journal of neuro-oncology, 2010, Volume: 100, Issue:1 Topics: Adult; Analysis of Variance; beta Catenin; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin D; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; RNA, Small Interfering; Time Factors	2010
Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies. Journal of neuro-oncology, 2011, Volume: 102, Issue:3 Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Adhesion; Cell Cycle; Cell Proliferation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Models, Animal; RNA, Messenger; SOXB1 Transcription Factors; Spheroids, Cellular; Time Factors; Tumor Cells, Cultured	2011
Low-power 808-nm laser irradiation inhibits cell proliferation of a human-derived glioblastoma cell line in vitro. Lasers in medical science, 2012, Volume: 27, Issue:1 Topics: Bromodeoxyuridine; Cell Count; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; DNA; Fluoresceins; Fluorescent Dyes; Glioblastoma; Humans; Low-Level Light Therapy	2012
Three-dimensional invasion of human glioblastoma cells remains unchanged by X-ray and carbon ion irradiation in vitro. International journal of radiation oncology, biology, physics, 2012, Nov-15, Volume: 84, Issue:4 Topics: Brain Neoplasms; Bromodeoxyuridine; Carbon; Cell Migration Assays; Cell Movement; Cell Proliferation; Collagen Type I; DNA Breaks, Double-Stranded; Glioblastoma; Histones; Humans; Integrin beta1; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Tumor Suppressor p53-Binding Protein 1	2012
The influence of bromodeoxyuridine on the induction and repair of DNA double-strand breaks in glioblastoma cells. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2002, Volume: 178, Issue:9 Topics: Bromodeoxyuridine; Culture Media; DNA Damage; DNA Fragmentation; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Radiation; Electrophoresis, Gel, Pulsed-Field; Fluorometry; Glioblastoma; Humans; Linear Models; Models, Biological; Radiation Dosage; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured	2002
Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo. Acta neuropathologica, 2004, Volume: 107, Issue:6 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; bcl-X Protein; Bromodeoxyuridine; Carrier Proteins; Caspase 3; Caspases; Cell Division; Cell Line, Tumor; Cell Transplantation; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Depsipeptides; Dose-Response Relationship, Drug; Exons; Glioblastoma; Histone Deacetylase Inhibitors; Humans; In Situ Nick-End Labeling; Matrix Metalloproteinase 2; Mice; Mice, Nude; Peptides, Cyclic; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Time Factors	2004
Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-01, Volume: 10, Issue:15 Topics: Animals; Antineoplastic Agents; Antitussive Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Bromodeoxyuridine; Cattle; Cell Count; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Coloring Agents; DNA; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Flow Cytometry; Glioblastoma; Humans; Image Processing, Computer-Assisted; Inhibitory Concentration 50; Mice; Mice, Nude; Mice, SCID; Microcirculation; Microtubules; Mitosis; Models, Biological; Neoplasm Transplantation; Neuroglia; Noscapine; Rats; S Phase; Time Factors; Tubulin	2004
Biphasic calcium response of platelet-derived growth factor stimulated glioblastoma cells is a function of cell confluence. Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2005, Volume: 67, Issue:2 Topics: Becaplermin; Bromodeoxyuridine; Calcium; Calcium Signaling; Cell Adhesion; Cell Cycle; Cells, Cultured; DNA; Glioblastoma; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Spectrometry, Fluorescence	2005
Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. The Journal of biological chemistry, 2006, Nov-10, Volume: 281, Issue:45 Topics: Bromodeoxyuridine; Cell Differentiation; Cell Lineage; Fluorescent Antibody Technique; Glioblastoma; Humans; Immunoblotting; Neural Crest; Neuroblastoma; Neurons; Nuclear Proteins; Polycomb Repressive Complex 1; Proto-Oncogene Proteins; Regeneration; Repressor Proteins; Retroviridae; Stem Cells; Tumor Cells, Cultured; Tumor Stem Cell Assay; Zinc Fingers	2006
Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death. Journal of neuro-oncology, 2008, Volume: 86, Issue:1 Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cisplatin; DNA Damage; Down-Regulation; Glioblastoma; Humans; Inhibitor of Growth Protein 1; Intracellular Signaling Peptides and Proteins; Nuclear Proteins; Radiation; RNA, Small Interfering; Time Factors; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2008
Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal. Journal of neuro-oncology, 2008, Volume: 86, Issue:3 Topics: Animals; Apoptosis; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Green Fluorescent Proteins; Humans; In Situ Nick-End Labeling; Osteopontin; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Survival Analysis; Time Factors; Transfection; Transplants	2008
Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:10 Topics: Bone Marrow; Bromodeoxyuridine; Drug Eruptions; Drug Evaluation; Glioblastoma; Humans; Infusions, Parenteral; Neoplasms; Radiation-Sensitizing Agents; Thrombocytopenia; Time Factors	1984
Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR). International journal of radiation oncology, biology, physics, 1983, Volume: 9, Issue:4 Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Evaluation; Female; Glioblastoma; Hematopoietic Stem Cells; Humans; Infusions, Parenteral; Male; Middle Aged; Radiation Tolerance	1983
[Adjuvant immunotherapy with levamisole for malignant glioma]. No to shinkei = Brain and nerve, 1983, Volume: 35, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Humans; Levamisole; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Vincristine	1983
DNA repair patch size measurements with nucleosomal DNA. Carcinogenesis, 1983, Volume: 4, Issue:8 Topics: Bromodeoxyuridine; Cell Line; DNA Repair; DNA Replication; Glioblastoma; Humans; Kinetics; Micrococcal Nuclease; Nucleosomes; Ultraviolet Rays	1983
A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:1 Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Middle Aged; Neoplasms; Radiation-Sensitizing Agents; Sarcoma	1984
Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer, 1994, Oct-01, Volume: 74, Issue:7 Topics: Adult; Affinity Labels; Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Epitopes; Female; Glioblastoma; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Paraffin Embedding; Regression Analysis; S Phase	1994
Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme. Neurosurgery, 1994, Volume: 35, Issue:2 Topics: Adult; Aged; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Intravenous; Male; Middle Aged; Mitotic Index; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Reoperation; Survival Rate	1994
Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme. Acta neuropathologica, 1994, Volume: 87, Issue:6 Topics: Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Nucleolus Organizer Region	1994
Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. International journal of cancer, 1993, Feb-20, Volume: 53, Issue:4 Topics: Age Factors; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Glioblastoma; Humans; Male; Prognosis; Survival Analysis	1993
Immunohistochemical double staining with immunogold-silver and alkaline phosphatase to identify nuclear markers of cellular proliferation. Biotechnic & histochemistry : official publication of the Biological Stain Commission, 1993, Volume: 68, Issue:1 Topics: Alkaline Phosphatase; Biomarkers; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; Glioblastoma; Humans; Idoxuridine; Immunohistochemistry	1993
Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms. Acta oncologica (Stockholm, Sweden), 1993, Volume: 32, Issue:3 Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Immunoenzyme Techniques; Male; Tumor Cells, Cultured	1993
In vitro effects of boron-containing compounds upon glioblastoma cells. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1997, Volume: 216, Issue:3 Topics: Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA Replication; Flow Cytometry; Fluorine Radioisotopes; Fructose; Glioblastoma; Humans; Phenylalanine; Tumor Cells, Cultured	1997
Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. British journal of cancer, 1998, Volume: 77, Issue:1 Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Glioblastoma; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Nude; Microscopy; Radiation-Sensitizing Agents; Regional Blood Flow; Transplantation, Heterologous	1998
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma mult International journal of radiation oncology, biology, physics, 1998, Feb-01, Volume: 40, Issue:3 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplastic; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Proportional Hazards Models; Radiation-Sensitizing Agents; Regression Analysis; Retrospective Studies	1998
Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter. Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:6 Topics: Aged; Animals; Antineoplastic Agents; Astrocytes; Bromodeoxyuridine; Cell Cycle; Enzyme Inhibitors; Female; Glioblastoma; Humans; Isoenzymes; Male; Mice; Mice, Inbred BALB C; Middle Aged; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured	1996
The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine. Cancer research, 2000, Nov-01, Volume: 60, Issue:21 Topics: Adenosine Triphosphate; Apoptosis; Bromodeoxyuridine; Cell Cycle; Deoxyadenine Nucleotides; Deoxycytidine; Gemcitabine; Glioblastoma; Humans; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2000
Post-operative stereotactic Curie-therapy using the iridium-192 GammaMed contact irradiation apparatus combined with radio-sensitizers in treating multiform glioblastomas. Acta neurochirurgica, 1978, Volume: 42, Issue:1-2 Topics: Brain Neoplasms; Bromodeoxycytidine; Bromodeoxyuridine; Deoxycytidine; Glioblastoma; Humans; Iridium; Postoperative Period; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Stereotaxic Techniques	1978
Simultaneous assessment of TGFB and cell cycle kinetics using IUdR/BrdU infusions in human neoplasms from plastic-embedded tissue. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1992, Volume: 40, Issue:3 Topics: Antibodies, Monoclonal; Biopsy; Bone Marrow; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Colonic Neoplasms; Female; Glioblastoma; Histological Techniques; Humans; Idoxuridine; Indicators and Reagents; Kinetics; Neoplasms; S Phase; Transforming Growth Factor beta	1992
Proliferative potential and outcome in pediatric astrocytic tumors. Journal of neuro-oncology, 1992, Volume: 13, Issue:3 Topics: Adolescent; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Infant; Male; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome	1992
Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections. Acta neurochirurgica, 1992, Volume: 117, Issue:3-4 Topics: Antigens, Neoplasm; Astrocytoma; Biomarkers, Tumor; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cerebellar Neoplasms; Craniotomy; Glioblastoma; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Medulloblastoma; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Neurilemmoma; Nuclear Proteins; Proliferating Cell Nuclear Antigen	1992
Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases. Journal of neurosurgery, 1991, Volume: 75, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Child, Preschool; Female; Glioblastoma; Humans; Infant; Male; Middle Aged; Regression Analysis; S Phase	1991
Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited. International journal of radiation oncology, biology, physics, 1991, Volume: 21, Issue:3 Topics: Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Glioblastoma; Humans; Radiation-Sensitizing Agents	1991
[Immunohistochemical study of S-phase cells in human gliomas]. No to shinkei = Brain and nerve, 1988, Volume: 40, Issue:8 Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Female; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Immunohistochemistry; Interphase; Male; Middle Aged; Staining and Labeling; Vimentin	1988
Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors. Journal of neurosurgery, 1989, Volume: 70, Issue:3 Topics: Aneuploidy; Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; DNA; Flow Cytometry; Glioblastoma; Humans; Immunoenzyme Techniques; Meningeal Neoplasms; Meningioma	1989
Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. Journal of neurosurgery, 1989, Volume: 71, Issue:3 Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Prognosis; Time Factors	1989
Variability in the proliferative potential of human gliomas. Journal of neuro-oncology, 1989, Volume: 7, Issue:2 Topics: Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Glioblastoma; Glioma; Humans; Interphase	1989
[Factors affecting the prognosis of brain tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:7 Topics: Age Factors; Antibodies, Monoclonal; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Epidermal Growth Factor; ErbB Receptors; Glioblastoma; Humans; Meningioma; Oligodendroglioma; Oncogenes; Prognosis	1988
Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta neuropathologica, 1985, Volume: 67, Issue:1-2 Topics: Aged; Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child, Preschool; Female; Glioblastoma; Glioma; Histocytochemistry; Humans; Immunochemistry; Interphase; Male; Meningioma; Middle Aged	1985
Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry, 1985, Volume: 6, Issue:6 Topics: Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Glioblastoma; Humans; Immunoenzyme Techniques; Interphase; Meningioma; Metabolic Clearance Rate	1985
Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bromodeoxyuridine) therapy and radiotherapy. Archives of dermatology, 1986, Volume: 122, Issue:2 Topics: Brain Neoplasms; Bromodeoxyuridine; Dermatitis, Exfoliative; Drug Eruptions; Glioblastoma; Humans; Male; Middle Aged; Radiation-Sensitizing Agents; Skin	1986
Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine. Neurosurgery, 1986, Volume: 19, Issue:6 Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cerebellar Neoplasms; Child; Child, Preschool; DNA, Neoplasm; Female; Glioblastoma; Humans; Immunoenzyme Techniques; Infant; Male; Medulloblastoma; Prognosis	1986
Proliferative potential of vascular components in human glioblastoma multiforme. Acta neuropathologica, 1987, Volume: 73, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Vessels; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cell Transformation, Neoplastic; Child; Endothelium; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local	1987
[Treatment of malignant brain tumors by BAR therapy]. No to shinkei = Brain and nerve, 1968, Volume: 20, Issue:6 Topics: Adolescent; Adult; Arteries; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Child; Ependymoma; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Meningioma; Middle Aged; Neoplasm Metastasis; Oligodendroglioma; Papilloma	1968
Current trends in the chemotherapy of brain tumors with special reference to glioblastomas. Journal of neurosurgery, 1969, Volume: 31, Issue:6 Topics: Alkaloids; Antibiotics, Antineoplastic; Antineoplastic Agents; Azaguanine; Blood Vessel Prosthesis; Blood-Brain Barrier; Brain; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Cell Transformation, Neoplastic; Disease Models, Animal; Fluorouracil; Glioblastoma; Humans; Injections, Intra-Arterial; Injections, Spinal; Mechlorethamine; Methotrexate; Nitroso Compounds; Thiotepa; Time Factors; Urea; Vincristine	1969
[Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)]. Acta neurochirurgica, 1971, Volume: 24, Issue:4 Topics: Adult; Aged; Alopecia; Brain Edema; Brain Neoplasms; Bromodeoxyuridine; Drug Interactions; Exanthema; Glioblastoma; Glossitis; Humans; Leukopenia; Methotrexate; Middle Aged; Postoperative Care; Prognosis; Radiation-Sensitizing Agents; Stomatitis; Thrombocytopenia	1971
[Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)]. No to shinkei = Brain and nerve, 1972, Volume: 24, Issue:5 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Child; Child, Preschool; Ependymoma; Female; Glioblastoma; Humans; Injections, Spinal; Male; Medulloblastoma; Meningioma; Methotrexate; Middle Aged; Mitomycins; Pinealoma; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Retinoblastoma	1972
[Clinical and experimental results of interstitial Curie-therapy combined with radiosensitizing agents in DS carcinoma of the rat and in infiltrating brain neoplasms]. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1972 Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carcinosarcoma; Cytidine; Ependymoma; Glioblastoma; Humans; Iridium; Methotrexate; Oligodendroglioma; Radiation-Sensitizing Agents; Rats; Thymidine	1972